Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN66,2566,3-0,47
Msft2,22
Nokia3,4193,4450,48
IBM0,62
Mercedes-Benz Group AG71,7271,750,94
PFE0,40
04.05.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 03.05.2024 16:05:52
JAPAN TOBACCO (2914.F, Frankfurt)
Závěr k 3.5.2024 Změna (%) Změna (EUR) Objem obchodů (EUR)
26,15 0,04 0,01 97 878
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.05.2024
Popis společnosti
Obecné informace
Název společnostiJapan Tobacco Inc
Ticker2914
Kmenové akcie:Ordinary Shares
RIC2914.T
ISINJP3726800000
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 53 239
Akcie v oběhu k 31.12.20231 775 307 972
MěnaJPY
Kontaktní informace
UliceKamiyacho Trust Tower, 4-1-1, Toranomon
MěstoMINATO-KU
PSČ105-6927
ZeměJapan
Kontatní osobaHiromasa Furukawa
Funkce kontaktní osobyExecutive Officer, Chief Financial Officer
Telefon81 366 362 914
Fax81355721441
Kontatní telefon810 366 362 914

Business Summary: Japan Tobacco Inc is a Japan-based company mainly engaged in the tobacco business, the pharmaceutical business and the processed food business. The Company operates through four business segments. The Domestic Tobacco segment is engaged in the production and sale of manufactured tobacco in Japan (including domestic duty-free market and China, Hong Kong and Macao markets under the jurisdiction of China Business Division). The International Tobacco segment is engaged in the production and sale of manufactured tobacco overseas. The Medical segment is engaged in the research, development, production and sale of medical drugs. The Food Processing segment is engaged in the manufacture and sale of frozen and ambient temperature processed foods, bakery, seasoning, among others. The Company is also involved in the leasing of real estate.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Japan Tobacco Inc revenues increased 7% to Y2.841T. Net income applicable to common stockholders increased 9% to Y482.29B. Revenues reflect Domestic Tobacco segment increase of 7% to Y2.591T, Tobacco overseas segment increase of 14% to Y94.88B, Other segment increase of 10% to Y2.156T. Net income benefited from Tobacco overseas segment income increase of 56% to Y17.41B.
Odvětvová klasifikace
TRBC2009Tobacco
TRBC2012Cigars & Cigarette Manufacturing
RBSS2004Tobacco
MGINDUSTRYTobacco
MGSECTORConsumer/Non-Cyclical
NAICSTobacco Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSFrozen Specialty Food Manufacturing
NAICSPerishable Prepared Food Manufacturing
NAICSCommercial Bakeries
NAICSSpice and Extract Manufacturing
NAICSLessors of Nonresidential Buildings (except Miniwarehouses)
NAICS2007Cigarette Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Soft Drink Mfg
NAICS2007Perishable Prepared Food Mfg
NAICS2007Fruit & Vegetable Canning
NAICS2007Spice & Extract Mfg
NAICS2007Other Tobacco Product Mfg
NAICS1997Cigarette Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Soft Drink Manufacturing
NAICS1997Perishable Prepared Food Manufacturing
NAICS1997Fruit and Vegetable Canning
NAICS1997Spice and Extract Manufacturing
NAICS1997Other Tobacco Product Manufacturing
SICCigarettes
SICPharmaceutical Preparations
SICFrozen Specialties, Nec
SICFood Preparations, Nec
SICBread, Cake And Related Products
SICNonresidential Building Operators



  • Poslední aktualizace: 05.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Executive Officer, Chief Director of Tobacco Business, Representative DirectorMasamichi Terabatake5801.01.2024
Executive Officer, Chief Financial OfficerHiromasa Furukawa-01.01.202401.01.2020
Vice President, Executive Officer, DirectorKei Nakano5601.01.2017
Senior Managing Executive Officer, Chief Executive Officer of Domestic Tobacco Business in Main Tabacco Business UnitJunichi Fukuchi-24.03.202122.06.2012
Executive OfficerIgor Dzaja-01.01.202401.01.2024
Executive Officer, Director of Pharmaceutical BusinessMuneaki Fujimoto-22.06.201222.06.2012
Executive OfficerTaku Fujiwara-01.01.202301.01.2023
Executive OfficerHiroyuki Fukuda-01.01.202301.10.2019
Executive OfficerOsamu Hirose-01.01.2020
Executive Officer, Chief Sustainability OfficerHisato Imokawa-01.01.202201.01.2020